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Summary 
 
  Previous trials conducted at Kansas State 
University demonstrated that melengesterol 
acetate (MGA) increased growth rates and 
tended to reduce chronic sickness in heifers 
naturally challenged with undifferentiated bo-
vine respiratory disease.  Our study was con-
ducted to gain further insight into the mode of 
action of MGA.  Crossbred heifers (n=47; 511 
lb) were used to evaluate effects of MGA on 
lung pathology and markers of inflammation 
in cattle after an intrabronchial Mannheimia 
haemolytica challenge.  On day 0, cattle were 
assigned to diets (54% concentrate) that pro-
vided 0 or 0.5 mg MGA per heifer daily.  On 
day 14 each heifer was intrabronchially inocu-
lated with M. haemolytica.  Blood samples 
were collected from each heifer immediately 
before inoculation and 12, 24, 48, 72, 96, 120, 
and 138 hours after inoculation.  Heifers were 
then euthanized for postmortem examination.  
After the challenge, heifers fed MGA had 
greater numbers of neutrophils and white 
blood cells, as well as greater serum haptoglo-
bin and fibrinogen concentrations.  The inci-
dence of post-challenge lung lesions was 
greater in heifers fed MGA, and lung lesion 
scores tended to be more severe in heifers fed 
MGA, compared with those of controls.  
These data indicate that MGA does not reduce 
inflammation in heifers 138 hours after M. 
haemolytica challenge, suggesting that there 
are other modes of action for the beneficial 
effects on growth and reduction of chronicity 
in feedlot heifers. 
 
 
Introduction 
 
 Undifferentiated bovine respiratory dis-
ease is the most costly disease plaguing the 
beef industry today.  Roughly 75% of sickness 
and 50% of death losses in feedlot cattle are 
attributable to bovine respiratory disease, with 
an estimated annual cost of $1 billion.  Bovine 
respiratory disease is a multifactorial complex 
that is influenced by viral infection, weaning, 
transportation, commingling, and temperature 
extremes.  Stress, coupled with a primary viral 
infection, can allow bacteria often found in the 
upper respiratory tract of healthy animals to 
proliferate in the lower respiratory tract.  
Mannheimia haemolytica is generally consid-
ered the most virulent and important pathogen 
associated with severe respiratory disease in 
feedlot cattle, inducing severe pneumonia 
characterized by local production of many in-
flammatory mediators and the influx and acti-
vation of inflammatory cells.  The first in-
flammatory cells to arrive are neutrophils, 
which accumulate at the site of infection in 
response to proteins called cytokines.  Pro-
inflammatory cytokines, which include tumor 
necrosis factor-alpha (TNF-α), activate the 
endothelium, causing it to express receptors 
(called cell-adhesion molecules) for inflam-
matory cells.  These receptors allow inflam-
matory cells to attach to the endothelium and 
emigrate out of the blood and into tissue 
spaces.  Overly activated inflammatory cells 
cause damage to the lung, and prolonged in-
flammation can lead to extensive and irrepa-
rable damage, leaving these areas of the lungs 
non-functional. 
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 Previous research from our laboratory in-
dicated that MGA, a synthetic progestin com-
monly used to suppress estrous in feedlot cat-
tle, improved growth rates and reduced 
chronic sickness in heifers naturally chal-
lenged with respiratory disease.  Similar com-
pounds have also been shown to alter inflam-
mation in other animal species.  Our study was 
conducted to evaluate the effects of MGA on 
biological markers of inflammation and lung-
tissue damage in heifers experimentally in-
fected with M. haemolytica.   
 
Procedures 
 
 Forty-eight crossbred heifers were pur-
chased from a local sale barn and transported 
to the K-State Beef Cattle Research Center in 
Manhattan, Kansas.  No antibiotics or vac-
cines were administered to the calves any time 
after arrival to avoid interfering with progres-
sion of the experimental infection, and heifers 
were acclimated to the facility for a period of 
1 to 5 weeks before being placed on the study.  
On day 0 of the experiment, calves were strati-
fied by weight and randomly assigned, within 
strata, to one of two diets formulated to pro-
vide 54% concentrate:46% roughage and ei-
ther 0 or 0.5 mg MGA per heifer daily.  On 
day 14, all heifers were weighed and M. 
haemolytica was intrabronchially inoculated 
into the lungs.  Blood samples were collected 
immediately before inoculation and 12, 24, 48, 
72, 96, 120, and 138 hours after inoculation.  
After the final blood collection, calves were 
euthanized and transported to the KSU Col-
lege of Veterinary Medicine Diagnostic Lab 
for necropsy.  Each animal was given a lung-
lesion score based on the percentage of each 
lung lobe affected by lesions according to the 
formula: total calculated lung-lesion score = 
[(left cranial % x 0.05) + (left posterior cranial 
% x 0.06) + (left caudal % x 0.32) + (right 
cranial % x 0.06) + (right posterior cranial % 
x 0.05) + (right middle % x 0.07) + (right cau-
dal % x 0.35) + (intermediate % x 0.04)].  
Complete blood cell counts were performed 
on smear slides. 
One heifer in the MGA treatment group 
died between 48 and 72 hours after inocula-
tion, and data from this heifer were excluded 
from the statistical analysis.  This heifer had 
severe pneumonia, which was considered to 
be the cause of death. 
 
Results and Discussion 
 
All heifers in this study exhibited mild 
signs of respiratory disease after challenge.  
Heifers that did not receive MGA had elevated 
circulating white blood cells at 12 and 24 
hours after the inoculation, but the increase 
was smaller than that observed for heifers fed 
MGA (P<0.01, Figure 1).  This rise in white 
blood cells was due in large part to an increase 
in circulating neutrophils at 12 and 24 hours 
after the challenge, with MGA leading to a 
greater increase in circulating neutrophils 
(P<0.01, Figure 2).  These findings are consis-
tent with an earlier trial in which MGA caused 
increased numbers of circulating neutrophils 
in heifers 4 hours after injection with E. coli 
lipopolysaccharide.  Progesterone and syn-
thetic progestins, in some animal species, re-
duce endothelial expression of cell-adhesion 
molecules.  We speculate that the larger num-
ber of circulating neutrophils in cattle fed 
MGA could be caused by a decrease in endo-
thelial cell-adhesion molecules, thus decreas-
ing subsequent neutrophil emigration into the 
lung tissue.  This reduced influx of neutrophils 
early after challenge in heifers fed MGA may 
have allowed bacteria to proliferate more 
readily in the lung, potentially explaining why 
MGA increased incidence of lung lesions 
(60.9% vs. 25.0%; P<0.02) and tended to in-
crease severity of lung lesions (lung-lesion 
score: 3.08% vs. 1.04%; P=0.06: Table 1) 138 
hours post-inoculation.  The serum TNF-α 
concentrations were marginally higher 
(P=0.13) for heifers fed no MGA (Figure 3).  
Increased serum TNF-α would be expected 
after M. haemolytica challenge, but no post-
challenge increase in TNF-α was detected.  
Possible explanations of this include a low 
virulence of the bacteria used, as evidenced by 
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the limited severity of lung lesions, or the 
challenge may have been insufficient to stimu-
late higher systemic concentrations of TNF-α.  
The lack of an effect of MGA on serum TNF-
α does not rule out the possibility that MGA 
decreased secretion of TNF-α or other pro-
inflammatory cytokines by blood cells in the 
lung, but this cannot be determined from our 
study because concentrations of TNF-α in the 
lungs were not measured. 
 
Concentrations of the acute-phase proteins 
(fibrinogen and haptoglobin) were elevated in 
both treatment groups after inoculation.  How-
ever, concentrations of fibrinogen (Figure 4) 
and haptoglobin (Figure 5) were not greater in 
cattle fed MGA, compared with controls, until 
72 and 96 hours after inoculation, respec-
tively.  These data further support the conten-
tion that the bacterial pathogens proliferated 
more readily in the lungs of heifers fed MGA, 
thus causing a more severe acute-phase re-
sponse later in the challenge period. 
 
Chronic inflammation is the result of an 
exaggerated inflammatory response that is of-
ten characterized as a reaction to products 
produced during the inflammatory response 
rather than to the initial pathogen.  Anti-
inflammatory agents have been shown to be 
useful in attenuating chronic inflammation, 
but are not generally accepted as beneficial in 
bacterial infections or low-severity inflamma-
tion because they hinder the body's ability to 
clear the pathogen.  Heifers in our study ex-
hibited mild clinical signs of respiratory dis-
ease after challenge.  The bacteria used had a 
limited ability to initiate an inflammatory re-
sponse, and it is possible that this played a 
role in the greater incidence of lesions in heif-
ers fed MGA.  The beneficial effects of MGA 
observed in a previous trial may have been 
due to greater incidence and severity of the 
natural disease challenge.  Heifers in the pre-
vious trial experienced a morbidity rate of 
75.6% and a mortality rate of 9.9%.   
 
MGA increased incidence and severity of 
lung lesions in heifers subjected to a mild ex-
perimental challenge with M. haemolytica.  
Results of our study suggest that the previ-
ously observed improvements in growth and 
reduction of chronicity in heifers with more 
severe, naturally occurring, undifferentiated 
respiratory disease was not due to an attenua-
tion of the inflammatory response to M. 
haemolytica.  Further studies need to be con-
ducted to examine the effects of MGA on res-
piratory disease in cattle. 
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Figure 1.  Circulating White Blood Cell Concentration of Heifers Fed Either 0 or 0.5 mg of 
MGA Daily for 20 Days and Inoculated on Day 14 with M. haemolytica.  Effect of treatment, 
P<0.01; effect of sampling time, P<0.01; effect of interaction between treatment and sampling time, 
P=0.80. 
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Figure 2.  Circulating Mature Neutrophils of Heifers Fed Either 0 or 0.5 mg of MGA Daily 
for 20 Days and Inoculated on Day 14 with M. haemolytica.  Effect of treatment, P<0.01; effect 
of sampling time, P<0.01; effect of interaction between treatment and sampling time, P=0.61. 
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Figure 3.   Serum TNF-α of Heifers Fed Either 0 or 0.5 mg of MGA Daily for 20 Days and 
Inoculated on Day 14 with M. haemolytica.  Effect of treatment, P=0.13; effect of sampling 
time, P=1.00; effect of interaction between treatment and sampling time, P=1.00. 
 
Figure 4.  Circulating Fibrinogen of Heifers Fed Either 0 or 0.5 mg of MGA Daily for 20 Days 
and Inoculated on Day 14 with M. haemolytica.  Effect of treatment, P<0.01; effect of sampling 
time, P<0.01; effect of interaction between treatment and sampling time, P=0.20. 
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Table 1.  Average Lung Scores 138 Hours After Inoculation with M. haemolytica for 
Heifers Fed 0 or 0.5 mg of MGA 
 MGA, mg/day  
Item 0.5 0 P-value 
Number of heifers 23 24 - 
Average scorea 3.08 1.04 <0.06 
aTotal calculated percentage lung-lesion score = [(left cranial % x 0.05) + (left posterior cra-
nial % x 0.06) + (left caudal % x 0.32) + (right cranial % x 0.06) + (right posterior cranial % x 
0.05) + (right middle % x 0.07) + (right caudal % x 0.35) + (intermediate % x 0.04)]. 
Figure 5.  Serum Haptoglobin of Heifers Fed Either 0 or 0.5 mg of MGA Daily for 20 Days and 
Inoculated on Day 14 with M. haemolytica.  Effect of treatment, P<0.01; effect of sampling time, 
P<0.01; effect of interaction between treatment and sampling time, P=0.56. 
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